Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
A SPAC I Acquisition Unit | ASCAU | May 28, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | May 28, 2024 | 11.16 | 0.00 |
A-Mark Precious Metals | AMRK | May 28, 2024 | 39.46 | +3.84 |
a.k.a Brands | AKA | May 28, 2024 | 14.84 | -11.19 |
A.O Smith | AOS | May 28, 2024 | 82.54 | -2.64 |
A10 Networks | ATEN | May 28, 2024 | 15.40 | +1.85 |
A2Z Smart Technologies | AZ | May 28, 2024 | 0.42 | +0.10 |
AAA - A Rated Corporate Bond Ishares | QLTA | May 28, 2024 | 46.55 | -0.53 |
Aadi Bioscience | AADI | May 28, 2024 | 1.88 | +2.17 |
AAON | AAON | May 28, 2024 | 77.68 | -0.74 |
AAR | AIR | May 28, 2024 | 70.80 | -0.74 |
Abacus Life | ABL | May 28, 2024 | 11.70 | +9.35 |
Abbott Laboratories | ABT | May 28, 2024 | 101.95 | -1.92 |
AbbVie | ABBV | May 28, 2024 | 155.34 | -1.10 |
AbCellera Biologics | ABCL | May 28, 2024 | 4.08 | +5.97 |
Abeona Therapeutics | ABEO | May 28, 2024 | 4.10 | +0.99 |
Abercrombie & Fitch | ANF | May 28, 2024 | 152.39 | +1.48 |
Aberdeen Asia-Pacificome Fund | FAX | May 28, 2024 | 2.65 | -0.38 |
Aberdeen Australia Equity Fund | IAF | May 28, 2024 | 4.26 | 0.00 |
Aberdeen Emerging Markets Fund | AEF | May 28, 2024 | 5.33 | 0.00 |
Aberdeen Global Fund | FCO | May 28, 2024 | 5.74 | -0.43 |
Aberdeen Global Infrastructure | ASGI | May 28, 2024 | 18.83 | -0.16 |
Aberdeen Income Credit Strategies Fund | ACP | May 28, 2024 | 6.68 | -0.30 |
Aberdeen Income Credit Strategies Pref | ACP-A | May 28, 2024 | 24.37 | 0.00 |
Aberdeen Japan Equity Fund | JEQ | May 28, 2024 | 5.91 | +0.17 |
Abits Group | ABTS | May 28, 2024 | 0.67 | +2.60 |
Abivax SA - American Depositary Shares | ABVX | May 28, 2024 | 13.73 | -0.94 |
Able View Global | ABLV | May 28, 2024 | 1.38 | -8.00 |
ABM Industries | ABM | May 28, 2024 | 46.55 | -0.68 |
Abrdn Global Dynamic Dividend Fund | AGD | May 28, 2024 | 9.66 | -0.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.